Key facts
- Notable investors include Innoangel Fund, Lingyi Capital, Galileo Venture, Shenzhen Nanshan Venture Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for OptoSeeker
- ·The full record, as it builds
Funding rounds
No funding rounds for OptoSeeker are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About OptoSeeker
Developer of photonic microfluidic systems designed for biomedical research and cellular engineering applications. The company offers optoelectronic manipulation, high-throughput single-cell analysis, digital microfluidics, and automated cell screening technologies, serving life science researchers and biopharmaceutical developers to conduct precise cellular assays, accelerate therapeutic discovery, and enhance experimental reproducibility through scalable, high-resolution, and programmable instrumentation.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2023
- Website
- optoseeker.com/
- Ownership
- Privately Held (backing)
OptoSeeker doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in OptoSeeker shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on OptoSeeker in its N-PORT filings yet. We sweep new filings monthly.